Edgewise

Edgewise Therapeutics price target lowered to $35 from $40 at Wedbush

6 days ago

Wedbush analyst Laura Chico lowered the firm’s price target on Edgewise Therapeutics (EWTX) to $35 from $40 and keeps an…